A role for the androgen metabolite, 5alpha androstane 3beta, 17beta Diol (3β-Diol) in the regulation of the hypothalamo-pituitary-adrenal axis

Frontiers in Endocrinology

Volumn 2, Issue NOV, 2011, Pages

  Handa, Robert J ^a   Sharma, Dharmendra ^b   Uht, Rosalie ^b  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH TEXAS   (United States)

Author keywords

3 diol; Androgen; Corticotropin releasing hormone; Estrogen receptor beta; Oxytocin; Paraventricular nucleus; Stress; Vasopressin

Indexed keywords

EID: 84860342981     PISSN: None     EISSN: 16642392     Source Type: Journal    
DOI: 10.3389/fendo.2011.00065     Document Type: Review

References (136)

1. Abdelgadire, S. E., Resko, J. A., Ojeda, S. R., Lephart, E. D., McPhaul, M. J., and Roselli, C. E. (1994). Andro-gens regulate aromatase cytochrome P450 messenger ribonucleic acid in rat brain. Endocrinology 135, 395-401.
2. Adan, R. A., and Burbach, J. P. (1992). Regulation of vasopressin and oxytocin gene expression by estrogen and thyroid hormone. Prog. Brain Res. 92, 127-136.
3. Adan, R. A., Cox, J. J., Beischlag, T. V., and Burbach, J. P. (1993). A composite hormone response element mediates the transactivation of the rat oxytocin gene by different classes of nuclear hormone receptors. Mol. Endocrinol. 7,47-57.
4. Aguilera, G., Nikodemova, M., Wynn, P. C., and Catt, K. J. (2004). Corti-cotropin releasing hormone receptors: two decades later. Peptides 25, 319-329.
5. Alves, S. E., Lopez, V., McEwen, B. S., andWeiland,N.G. (1998). Differential colocalization of estrogen receptor beta (ERbeta) with oxytocin and vasopressin in the paraventricular and supraoptic nuclei of the female rat brain: an immunocytochemical study. Proc. Natl. Acad. Sci. U.S.A. 95, 3281-3286.
6. Angold, A., Costello, E. J., Erkanll, A., and Worthman, C. M. (1999). Pubertal changes in hormone levels and depression in girls. Pyschol. Med. 29,1043-1053
7. Angold, A., and Worthman, C. W. (1993). Puberty onset of gender differences in rates of depression: a developmental, epidemi-ologic and neuroendocrine perspective. J. Affect. Disord. 29, 145-158.
8. Bannister, A. J., Oehler, T., Wilhelm, D., Angel, P., and Kouzarides, T. (1995). Stimulation of c-Jun activity by CBP: c-Jun residues Ser63/73 are required for CBP induced stimulation in vivo and CBP binding in vitro. Oncogene 11,2509-2514.
9. Bauman, D. R., Steckelbroeck, S., Williams, M. V., Peehl, D. M., and Penning, T. M. (2006). Identificatin of the major oxidative 3alpha-hydroxysteroid dehydrogenase in human prostate that converts 5alph-androstane-3alpha, 17beta-diiol to 5alpha-dihydrotestosterone: a potential therapeutic target for androgen-dependent disease. Mol. Endocrinol. 20, 444-458.
10. Bingaman, E. W., Magnuson, D. J., Gray, T. S., and Handa, R. J. (1994a). Androgen inhibits the increases in hypothalamic corticotropin-releasing hormone (CRH) and CRH-immunoreactivity following gonadectomy. Neuroendocrinology 59, 228-234.
11. Bingaman, E. W., Baeckman, L. M.,Yra-cheta, J. M., Handa, R. J., and Gray, T. S. (1994b). Localization of androgen receptor within peptidergic neurons of the rat forebrain. Brain Res. Bull. 35, 379-382.
12. Bingham, B., Williamson, M., and Viau, V. (2006). Androgen and estrogen receptor-beta distribution within spinal-projecting and neurosecre-tory neurons in the paraventricular nucleus of the male rat. J. Comp. Neurol. 499, 911-923.
13. Bondy, C. A., Whitnall, M. H., Brady, L. S., and Gainer, H. (1989). Coexisting peptides in hypothalamic neuroendocrine systems: some functional implications. Cell. Mol. Neurobiol. 9, 427-446.
14. Burbach, J. P., Lopes da Silva, S., Cox, J. J., Adan, R. A., Cooney, A. J., Tsai, M. J., and Tsai, S. Y. (1994). Repression of estrogen-dependent stimulation of the oxytocin gene by chicken ovalbumin upstream promoter transcription factorI. J. Biol. Chem. 269, 15046-15053.
15. Burgess, L. H., and Handa, R. J. (1992). Chronic estrogen-induced alterations in adrenocorticotropin and corticosterone secretion and gluco-corticoid receptor-mediated functions in female rats. Endocrinology 131, 1261-1269.
16. Caldwell, H. K., Lee, H. J., Macbeth, A. H., and Young, W E. III. (2008). Vasopressin: behavioral roles of an "original" neuropeptide. Prog. Neurobiol. 84, 1-24.
17. Choi, D. C., Furay, A. R., Evanson, N. K., Ostrander, M. M., Ulrich-Lai, Y. M., and Herman, J. P. (2007). Bed nucleus of the stria termi-nalis subregions differentially regulate hypothalamic-pituitary-adrenal axis activity: implications for the integration of limbic inputs. J. Neu-rosci. 27, 2025-2034.
18. Chu, K., and Zingg, H. H. (1999). Activation of the mouse oxytocin promoter by the orphan receptor RORalpha. J. Mol. Endocrinol. 23, 337-346.
19. Chung, S., Son, G. H., and Kim, K. (2011). Circadian rhythm of adrenal glucocorticoid: its regulation and clinical implications. Biochem. Bio-phys.Acta 1812,581-591.
20. Coyne, M. D., and Kitay, J. I. (1971). Effect of orchiectomy on pituitary secretion of ACTH. Endocrinology 89,1024-1028.
21. Cullinan, W. E., Helmreich, D. L., and Watson, S. J. (1996). Fos expression in forebrain afferents to the hypothalamic paraventricular nucleus following swim stress. J. Comp. Neurol. 368, 88-99.
22. Cyranowski, J. M., Hofkens, T. L., Frank, E., Seltman, H., Cai, H. M., and Ami-cao, J. A. (2008). Evidence of dysreg-ulated peripheral oxytocin release among depressed women. Psyhosom. Med. 70, 967-975.
23. Dellovade, T. L., Zhu, Y. S., and Pfaff, D. W (1999). Thyroid hormones and estrogen affect oxytocin gene expression in hypothalamic neurons. J. Neuroendocrinol. 11, 1-10.
24. Diamond, M. I., Miner, J. N., Yoshi-naga, S. K., and Yamamoto, K. R. (1990). Transcription factor interactions: selectors of positive or negative regulation from a single DNA element. Science 249, 1266-1272.
25. Estacio, M. A., Yamada, S., Tsukamura, H., Hirunagi, K., and Maeda, K. (1996). Effect of fasting and immobilization stress on estrogen receptor immunoreactivity in the brain in ovariectomized female rats. Brain Res. 717, 55-61.
26. Fava, M., and Kendler, K. S. (2000). Major depressive disorder. Neuron 28,335-341.
27. Follib, A., Lui, P., and Romeo, R. (2011). The transformation of hormonal stress responses throughout puberty and adolescence. J. Endocrinol. 210, 391-398.
28. Gangloff, A., Shi, R., Nahoum, V., and Lin, S. X. (2003). Pseudo-symmetry of C19 steroids, alternative binding orientations, and multispecificity in human estro-genic 17beta-hydroxysteroid dehydrogenase. FASEBJ. 17,274-276.
29. Gaskin, J. H., and Kitay, J. I. (1970). Adrenocortical function in the hamster. Sex differences and effects of gonadal hormones. Endocrinology 87, 779-786.
30. Gaskin, J. H., and Kitay, J. I. (1971). Hypothalamic and pituitary regulation of adrenocortical function in the hamster: effects of gonadectomy and gonadal hormone replacement. Endocrinology 89, 1047-1053.
31. Gillies, G. E., Linton, E. A., and Lowry, P. J. (1982). Corticotropin releasing activity of the new CRF is potentiated several times by vasopressin. Nature 299, 355-357.
32. Gomez, F., De Kloet, E. R., and Armario, A. (1998). Glucocorticoid negative feedback on the HPA axis in five inbred rat strains. Am. J. Physiol. 274, R420-R427.
33. ;, S'-monophosphate-stimulated corticotropin-releasing hormone-reporter expression in AtT-20 cells. Mol. Endocrinol. 10, 317-329.
34. Handa, R. J., Nunley, K. M., Lorens, S. A., Louie, J. P., McGivern, R. F., and Bollnow, M. R. (1994a). Androgen regulation of adrenocorticotropin and corticosterone secretion in the male rat following novelty and foot shock stressors. Physiol. Behav. 55, 117-124.
35. Handa, R. J., Burgess, L. H., Kerr, J. E., and O'Keefe, J. A. (1994b). Gonadal steroid hormone receptors and sex differences in the hypothalamo-pituitary-adrenal axis. Horm. Behav. 28, 464-476.
36. Herman, J. P., Prewitt, C. M., and Cullinan, W. E. (1996). Neuronal circuit regulation of the hypothalamo-pituitary-adrenocortical stress axis. Crit. Rev. Neurobiol. 10, 371-394
37. Hettema, J. M., Neale, M. C., and Kendler, K. S. (2001). A review and meta-analysis of the genetic epidemiology of anxiety disorders. Am. J. Psychiatry 158, 1568-1578.
38. Heuser, I., Yassouridis, A., and Hols-boer, E (1994). The combined dex-amethasone/CRH test: a refined laboratory test for psychiatric disorders. J. Psychiatr. Res. 28, 341-356.
39. Hrabovsky, E., Kallo, I., Hajszan, T., Shughrue, P. J., Merchenthaler, I., and Liposits, Z. (1998). Expression of estrogen receptor beta messenger ribonucleic acid in oxy-tocin and vasopressin neurons of the rat supraoptic and paraven-tricular nuclei. Endocrinology 139, 2600-2604.
40. Huang, Q., Zhu, H., Fischer, D. F., and Zhou, J. N. (2008). An estro-genic effect of 5alpha-androstane-3beta, 17beta-diol on the behavioral response to stress and on CRH regulation. Neuropharmacology 54, 1233-1238.
41. Isgor, C., Cecchi, M., Kabbaj, M., Akil, H., and Watson, S. J. (2003). Estrogen receptor beta in the paraventric-ular nucleus of hypothalamus regulates the neuroendocrine response to stress and is regulated by corticos-terone. Neuroscience 121, 837-845.
42. Jin, Y., and Penning, T. M. (2001). Steroid 5alpha-reductases and 3alpha-hydroxysteroid dehydroge-nases: key enzymes in androgen metabolism. Best Pract. Res. Clin. Endocrinol. Metab. 15, 79-94.
43. Kalsbeek, A., van der Vliet, J., and Buijs, R. M. (1996). Release of endogenous vasopressin release necessary for the expression of the circa-dian rise in plasma corticosterone: a reverse micro dialysis study. J. Neu-roendocrinol. 8, 299-307.
44. Kasckow, J. W., Regmi, A., Seasholtz, A. E, and Mulchahey, J. J. (1999). Regulation of corticotropin-releasing factor-binding protein expression in amygdalar neuronal cultures. J. Neu-roendocrinol. 11,959-966.
45. Kendler, K. S. (1998). Gender differences in the genetic epidemiology of major depression. J. Gend. Specif. Med. 1,28-31.
46. Kessler, R. C. (2003). Epidemiology of women and depression. J. Affect. Disord. 74, 5-13.
47. Kitay, J. I. (1963). Effects of estradiol on pituitary-adrenal function in male and female rats. Endocrinology 72, 947-954.
48. Kitay, J. I. (1965). Effects of oophorec-tomy and various doses of estroadiol-17beta on cortios-terone production by rat adrenal slices. Proc. Soc. Exp. Biol. Med. 120, 193-196.
49. Koohi, M. K., Ivell, R., and Walther, N. (2005). Transcriptional activation of the oxytocin promoter by oestrogens uses a novel non-classical mechanism of oestrogen receptor action. J. Neuroendocrinol. 17,197-207.
50. Krieger, N. R., Scott, R. G., and Jurman, M. E. (1983). Testosterone 5 alpha-reductase in rat brain. J. Neurochem. 40, 1460-1464.
51. Kuiper, G. G., Carlsson, B., Grandien, K., Enmark, E., Haggblad, J., Nilsson, S., and Gustafsson, J. A. (1997). Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 138, 863-870.
52. Kuiper, G. G., Enmark, E., Pelto-Huikko, M., Nilsson, S., and Gustafsson, J. A. (1996). Cloning of a novel receptor expressed in rat prostate and ovary. 93,5925-5930.
53. Kushner, P. J., Agard, D. A., Greene, G. L., Scanlan, T. S., Shiau, A. K., Uht, R. M., and Webb, P. (2000). Estrogen receptor pathways to AP-1. J. Steroid Biochem. Mol. Biol. 74, 311-317.
54. Laflamme, N., Nappi, R. E., Dro-let, G., Labrie, C., and Rivest, S. (1998). Expression and neuropep-tidergi characterization of estrogen receptors (ERalpha and ERbeta) throughout the rat brain: anatomical evidence of distinct roles of each subtype. J. Neurobiol. 36, 357-378.
55. Lalmansingh, A. S., and Uht, R. M. (2008). Estradiol regulates corticotropin-releasing hormone gene (crh) expression in a rapid and phasic manner that parallels estrogen receptor-alpha and -beta recruitment to a 3,5-cyclic adeno-sine 5'-monophosphate regulatory region of the proximal crh promoter. Endocrinology 149, 346-357.
56. Landgraf, R., and Neumann, I. D. (2004). Vasopressin and oxytocin release within the brain: a dynamic concept of multiple and variable modes of neuropeptide communication. Front. Neuroendocrinol. 25, 150-176.
57. Lefstin, J. A., and Yamamoto, K. R. (1998). Allosteric effects of DNA on transcriptional regulators. Nature 392,885-888.
58. Lipkin, S. M., Nelson, C. A., Glass, C. K., and Rosenfeld, M. G. (1992). A negative retinoic acid response element in the rat oxytocin promoter restricts transcriptional stimulation by heterologous transactiva-tion domains. Proc. Natl. Acad. Sci. U.S.A. 89, 1209-1213.
59. Lopes da Silva, S., and Burbach, J. P. (1995). The nuclear hormone-receptor family in the brain: classics and orphans. Trends Neurosci. 18, 542-548.
60. Lund, T. D., Hinds, L. R., and Handa, R. J. (2006). The androgen 5alpha-dihydrotestosterone and its metabolite 5alpha androstan-3beta, 17beta-diol inhibit the hypothalamo-pituitary-adrenal response to stress by acting through estrogen receptor beta-expressing neurons in the hypothalamus. J. Neurosci. 26, 1448-1456.
61. Lund, T. D., Munson, D. J., Haldy, M. E., and Handa, R. J. (2004a). Dihydrotestosterone may inhibit hypothalamo-pituitary-adrenal activity by acting through estrogen receptor in the male mouse. Neurosci. Lett. 365, 43-47.
62. Lund, T. D., Munson, D. J., Haldy, M. E., and Handa, R. J. (2004b). Androgen inhibits, while oestrogen enhances, restraint-induced activation of neuropeptide neurons in the paraventricular nucleus of the hypothalamus. J. Neuroendocrinol. 16, 272-278.
63. Lund, T. D., Rovis, T., Chung, W. C., and Handa, R. J. (2005). Novel actions of estrogen receptor-beta on anxiety-related behaviors. Endocrinology 146, 797-807.
64. Malkoski, S. P., and Dorin, R. I. (1999). Composite glucocorti-coid regulation at a functionally defined negative glucocorti-coid response element of the human corticotropin-releasing hormone gene. Mol. Endocrinol. 13, 1629-1644.
65. Malkoski, S. P., Handanos, C. M., and Dorin, R. I. (1997). Localization of a negative glucocorticoid response element of the human corticotropin releasing hormone gene. Mol. Cell. Endocrinol. 127, 189-199.
66. Mayer, C. M., Fick, L. J., Gingerich, S., and Belsham, D. D. (2009). Hypothalamic cell lines to investigate neuroendocrine control mechanisms. Front. Neuroendocrinol. 30, 405-423.
67. McKenna, N. J., Xu, J., Nawaz, Z., Tsai, S. Y., Tsai, M.-J., and O'Malley, B. W (1999). Nuclear receptor coac-tivators: multiple enzymes, multiple complexes, multiple functions. J. Steroid Biochem. Mol. Biol. 69, 3-12.
68. Melcangi, R. C., Celotti, F., Negri-Cesi, P., and Martini, L. (1985). Testosterone 5 alpha-reductase in discrete hypothalamic nuclear areas in the rat: effect of castration. Steroids 45, 347-356.
69. Miller, W. J., Suzuki, S., Miller, L. K., Handa, R., and Uht, R. M. (2004). Estrogen receptor (ER) beta isoforms rather than Eralpha regulate corticotropin-releasing hormone promoter activity through an alternate pathway. J. Neurosci. 24, 10628-10635.
70. Murray, C. J., and Lopez, A. D. (1997). Global mortality, disability and the contribution of risk factors: global burden of disease study. Lancet 349, 1436-1442.
71. Nader, N., Chrousos, G. P., and Kino, T. (2010). Interactions of the circa-dian CLOCK system and the HPA axis. Trends Endocrinol. Metab. 21, 277-286.
72. Naftolin, F. (1994). Brain aromatization of androgens. J. Reprod. Med. 39, 57-261.
73. Nemeroff, C. B., Widerlov, E., Bis-sette, G., Walleus, H., Karlsson, I., Eklund, K., Kilts, C. D., Loosen, P. T., and Vale, W. (1984). Elevated concentrations of CSF corticotropin-releasing factor-like immunoreac-tivity in depressed patients. Science 226, 1342-1344.
74. Neumann, I. D. (2007). Stimuli and cnosequences of dendritic release of oxytocin within the brain. Biochem. Soc. Trans. 35,1252-1257.
75. Neumann, I. D., Kromer, S. A., Toschi, N., and Ebner, K. (2000). Brain oxytocin inhibits the (re)activity of the hypothalamo-pituitary-adrenal axis in male rats: involvement of hypothalamic and limbic brain regions. Regul. Pept. 96, 31-38.
76. Ogura, E., Kageyama, K., Hanada, K., Kasckow, J., and Suda, T. (2008). Effects of estradiol on regulation of corticotropin-releasing factor gene and interleukin-6 production via estrogen receptor type beta in hypothalamic 4B cells. Peptides 29, 456-464.
77. Orchedalski, T., Subbaraju, S., Wynn, P. C., and Aguilera, G. (2007). Interaction between oestrogen and oxytocin on hypothalamic-pituitary-adrenal axis activity. J. Neuroendocrinol. 19, 189-197.
78. Osborne, D. M., Edinger, K., and Frye, C. A. (2009). Chronic administration of androgens with actions at estrogen receptor beta have anti-anxiety and cognitive enhancing effects in male rats. Age (Dordr.) 31, 191-198.
79. Oster, H., Damerow, S., Kiessling, S., Jakubcakova, V., Abraham, D., Tian, J., Hoffmann, M. W., and Eichele, G. (2006). The circadian rhythm of glucocorticoids is regulated by a gating mechanism residing in the adrenal cortical clock. Cell Metab. 4, 163-173.
80. Palkovits, M. (2000). Stress-induced expression of co-localized neu-ropeptides in hypothalamic and amygdaloid neurons. Eur. J. Pharmacol. 405, 161-166.
81. Pak, T. R., Chung, W. C., Hinds, L. R., and Handa, R. J. (2007). Estrogen receptor-beta mediates dihydrotestosterone-induced stimulation of the arginine vaso-pressin promoter in neuronal cells. Endocrinology 148, 3371-3382.
82. Papadimitriou, A., and Priftis, K. N. (2009). Regulation of the hypothalamic-pituitary-adrenal axis. Neuroimmunomodulation 16, 265-271.
83. Parker, K. J., Kenna, H. A., Zeitzer, J. M., Keller, J., Blasey, C. M., Amico, J. A., and Schatzberg, A. E (2010). Preliminary evidence that plasma oxy-tocin levels are elevated in major depression. Pyschiatry Res. 178, 359-362.
84. Pendergast, J. S., Tuesta, L. M., and Bethea, J. R. (2008). Oestrogen receptor beta contributes to the transient sex difference in tyrosine hydroxylase expression in the mouse locus coeruleus. J. Neuroendocrinol. 20,1155-1164.
85. Penning, T. M., Bauman, D. R., Jin, Y., and Rizner, T. L. (2007). Identification of the molecular switch that regulates access of 5alpha-DHT to the androgen receptor. Mol. Cell. Endocrinol. 265-266, 77-82.
86. Purba, J. S., Hoogendijk, W. J., Hof-man,M.A.,andSwaab,D. E (1996). Increased number of vasopressin-and oxytocin-expressing neurons in the paraventricular nucleus of the hypothalamus in depression. Arch. Gen. Psychiatry 53, 137-143.
87. Raadsheer, E C., Sluiter, A. A., Ravid, R., Tilders, E J., and Swaab, D. E (1993). Localization of corticotropin-releasing hormone (CRH) neurons in the paraventricular nucleus of the human hypothalamus; age-dependent co localization with vasopressin. Brain Res. 615, 50-62.
88. Raadsheer, F. C., Tilders, F. J., and Swaab, D. E (1994). Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients. Neu-roendocrinology 60, 436-444.
89. Richard, S., and Zingg, H. H. (1990). The human oxytocin gene promoter is regulated by estrogens. J. Biol. Chem. 265, 6098-6103.
90. Richard, S., and Zingg, H. (1991). Identification of a retinoic acid response element in the human oxytocin promoter. J. Biol. Chem. 266, 21428-21433.
91. Rivier, C., and Vale, W. (1983). Interaction of corticotropin-releasing factor and arginine vasopressin on adrenocorticotropin secretion in vivo. Endocrinology 113, 939-942.
92. Romeo,R.D.,andMcEwen,B.S. (2006). Stress and the adolescent brain. Ann. N. Y.Acad. Sci. 1094,202-214.
93. Romeo, R. D., Lee, S. J., Chua, N., McPherson, C. R., and McEwen, B.S. (2004). Testosterone cannot activate an adult-like stress response in pre-pubertal male rats. Neuroendocrinol-ogy 79, 125-132.
94. Rosen, M. P., and Cedars, M. I. (2007). "Female reproductive endocrinology and infertility," in Greenspans's Basic and Clinical Endocrinology, 8th Edn, eds D. G. Gardner and D. Shoback (New York, NY: McGraw Hill Medical) 502-562.
95. Rubin, R. T., Phillips, J. J., McCracken, J. T., and Sadow, T. E (1996). Adrenal gland volume in major depression: relationship to basal and stimulated pituitary-adrenal cortical axis function. Biol. Pyschiatry. 40, 89-97.
96. Rubin, R. T., Poland, R. E., Lesser, I. M., Winston, R. A., and Blodgett, A. L. (1987). Neuroendocrine aspects of primary endogenous depression. I. Cortisol secretory dynamics in patients and matched controls. Arch. Gen Psychiatry 44, 328-365.
97. Safe, S., and Kim, K. (2008). Non-classical genomic estrogen receptor (ER)/specificity protein and ER/activating protein-1 signaling pathways. J. Mol. Endocrinol. 41, 263-275.
98. Scantamburlo, G., Hansenne, M., Fuchs, S., Pitchot, W., Marechal, P., Pequeux, C., Ansseau, M., and Legros, J. J. (2007). Plasma oxytocin levels and anxiety in patients with major depression. Psychoneurendocrinology 32, 407-410.
99. Schlosser, S. F., Almeida, O. F., Patchev, V. K., Uassouridis, A., and Elands, J. (1994). Oxytocin-stimuated release of adrenocorticotropin from the rat pituitary is mediated by arginine vasopressin receptors of the V1b type. Endocrinology 135,2058-2063.
100. Seasholtz, A. F., Thompson, R. C., and Douglass, J. O. (1988). Identification of a cyclic adeno-sine monophosphate-responsive element in the rat corticotropin-releasing hormone gene. Mol. Endocrinol. 2, 1311-1319.
101. Selye, H. A. (1936). Syndrome produced by diverse nocuous agents. Nature 138,32.
102. Selye, H. A. (1975). Confusion and controversy in the stress field. J. Human Stress 1, 37-44.
103. Shapiro, R. A., Xu, C., and Dorsa, D. M. (2000). Differential transcrip-tional regulation of rat vasopressin gene expression by estrogen receptor alpha and beta. Endocrinology 141, 4056-4064.
104. Shughrue, P. J., Lane, M. V., and Merchenthaler, I. (1997). Comparative distribution of estrogen receptor alpha and beta mRNA in the rat central nervous system. J. Comp. Neurol. 388, 507-525.
105. Shughrue, P. J., and Merchenthaler, I. (2001). Distribution of estrogen receptor beta immunoreactivity in the rat central nervous system. J. Comp. Neurol. 436, 64-81.
106. Simerly, R. B., Chang, C., Muramatsu, M., and Swanson, L. W. (1990). Distribution of androgen and estrogen receptor mRNA-containing cells in the rat brain: an in situ hybridization study. J. Comp. Neurol. 294, 76-95.
107. Somponpun, S. J., and Sladek, C. D. (2003). Osmotic regulation of estrogen receptor-beta in rat vasopressin and oxytocin neurons. J. Neurosci. 23,4261-4269.
108. Steckelbroeck, S., Jin, Y., Gopishetty, S., Oyesanmi, B., and Penning, T. M. (2004). Human cytosolic 3alpha-hydroxysteroid dehydroge-nases of the aldo-keto reductase superfamily display significant 3beta-hydroxysteroid dehydro-genase activity: implications for steroid hormone metabolism and action. J. Biol. Chem. 279, 10784-10795.
109. Stedronsky, K., Telgmann, R., Tillmann, G., Walther, N., and Ivell, R. (2002). The affinity and activity of the multiple hormone response element in the proximal promoter of the human oxytocin gene. J. Neuroendocrinol. 14, 472-485.
110. Suzuki, S., and Handa, R. J. (2004). Regulation of estrogen receptor-beta expression in the female rat hypothalamus: differential effects of dexamethasone and estradiol. Endocrinology 145, 3658-3670.
111. Suzuki, S., and Handa, R. J. (2005). Estrogen receptor-beta, but not estrogen receptor-alpha is expressed in prolactin neurons of the female rat paraventricular and supraoptic nuclei: comparison with other neu-ropeptides. J. Comp. Neurol. 484, 28-42.
112. Suzuki, S., Lund, T. D., Price, Jr. R. H., and Handa, R. J. (2001). "Sex differences in the hypothalamo-pituitary-adrenal axis: novel roles for androgen and estrogen receptors," in Recent Research Developments in Endocrinology, Vol. 2, ed. S. G. Pandalai (Trivandrum: Transworld Research Network), 69-86.
113. Szafarczyk, A., Ixart, G., Alonso, G., Malaval, F., Nouguier-Soule, J., and Assenmacher, I. (1983). CNS control of the circadian adrenocorti-cal rhythm. J. Steroid Biochem. 19, 1009-1015.
114. Ustun, T. B., Ayuso-Mateos, J. L., Chat-terji, S., Mathers, C., and Murray, C. E (2004). Global burden of depressive disorders in the year (2000). Br. J. Psychiatry 184, 386-392.
115. Vamvakopoulos, N. C., and Chrousos, G. P. (1993). Evidence of direct estrogenic regulation of human corticotropin-releasing hormone gene expression. Potential implications for the sexual dimophism of the stress response and immune/inflammatory reaction. J. Clin. Invest. 92,1896-1902.
116. Van Londen, L., Goekoop, J. G., van Kempen, G. M., Frankhuijzen-Sierevogel, A. C., Wiegant, V M., van der Velde, E. A., and De Wied, D. (1997). Plasma levels of arginine vasopressin elevated in patients with major depression. Neuropsychophar-macology 17,284-292.
117. Viau, V (2002). Functional crosstalk between the hypothalamic-pituitary-gonadal and adrenal axes. J. Neuroendocrinol. 14,506-513.
118. Viau, V., Bingham, B., Davis, J., Lee, P., and Wong, M. (2005). Gender and puberty interact on the stress-induced activation of par-vocellular neurosecretory neurons and corticotropin-releasing hormone messenger ribonucleic acid expression in the rat. Endocrinology 146, 137-146.
119. Viau, V., Lee, P., Sampson, J., and Wu, J. (2003). A testicular influence on restraint-induced activation of medial parvocellular neurons in the paraventricular nucleus in the male rat. Endocrinology 144, 3067-3075.
120. Viau, V., and Meaney, M. J. (1991). Variations in the hypothalamic-pituitary-adrenal response to stress during the estrous cycle in the rat. Endocrinology 129, 2503-2511.
121. Viau, V., and Meaney, M. J. (1996). The inhibitory effect of testosterone on hypothalamic-pituitary-adrenal responses to stress is mediated by the medial preoptic area. J. Neurosci. 16, 1866-1876.
122. Viau, V and Meaney, M. J. (2004). Testosterone-dependent variations in plasma and intrapituitary cor- ticosteroid binding globulin and stress hypothalamic-pituitary-adrenal activity in the male rat. J. Endocrinol. 181,223-231.
123. Viau, V., Soriano, L., and Dallman, M. E (2001). Androgens alter cor-ticotropin releasing hormone and arginine vasopressin mRNA within forebrain sites known to regulate activity in the hypothalamic-pituitary-adrenal axis. J. Neuroendocrinol. 13, 442-445.
124. Walf, A., Rhodes, M. E., and Frye, C. A. (2004). Antidepressant effects of ERbeta-selective estrogen receptor modulators in the forced swim test. Pharmacol Biochem. Behav. 78, 523-529.
125. Wang, C. P., Lee, Y. F., Chang, C., and Lee, H. J. (2006). Transactivation of the proximal promoter of human oxytocin gene by TR4 orphan receptor. Biochem. Biophys. Res. Commun. 351,204-208.
126. Warren, M. P., and Brooks-Gunn, J. (1989). Mood and behavior at adolescence: evidence for hormonal factors. J. Clin. Endocrinol. Metab. 69, 77-83.
127. Wehrenberg, U., Ivell, R., Jansen, M., Von Goedecke, S., and Walther, N. (1994). Two orphan receptors binding to a common site are involved in the regulation of the oxytocin gene in the bovine ovary. Proc. Natl. Acad. Sci. U.S.A. 91, 1440-1444.
128. Weihua, Z., Makela, S., Andersson, L. C., Salmi, S., Saji, S., Webster, J. I., Jensen, E. V., Nilsson, S., Warner, M., and Gustafsson, J. A. (2001). A role for estrogen receptor beta in the regulation of growth of the ventral prostate. Proc. Natl. Acad. Sci. U.S.A. 98, 6330-6335.
129. Weihua, Z., Warner, M., and Gustafsson, J. A. (2002). Estrogen receptor beta in the prostate. Mol. Cell. Endocrinol. 193, 1-5.
130. Weiser, M. J., and Handa, R. J. (2009). Estrogen impairs gluco-corticoid dependent negative feedback on the hypothalamic-pituitary-adrenal axis via estrogen receptor alpha within the hypothalamus. Neuroscience 159, 883-895.
131. Weiser, M. J., Wu, T. J., and Handa, R. J. (2009). Estrogen receptor-beta agonist diarylpropionitrile: biological activities of R- and S-enantiomers on behavior and hormonal response to stress. Endocrinology 150, 1817-1825.
132. Whitnall, M. H. (1988). Distributions of pro-vasopressin expressing and pro-vasopresin deficient CRH neurons in the paraventricular hypothalamic nucleus of colchicine-treated normal and adrenalec-tomized rats. J. Comp. Neurol. 275, 13-28.
133. Williamson, M., Bingham, B., Gray, M., Innala, L., and Viau, V. (2010). The medial preoptic nucleus integrates the central influences of testosterone on the paraventricular nucleus of the hypothalamus and its extended circuitries. J. Neurosci. 30, 11762-11770.
134. Williamson, M., and Viau, V (2007). Androgen receptor expressing neurons that project to the paraventricular nucleus of the hypothalamus in the male rat. J. Comp. Neurol. 503, 717-740.
135. Windle, R. J., Shanks, N., Light-man, S. L., and Ingram, C. D. (1997). Central oxytocin administration reduces stress-induced corti-costerone release and anxiety behavior in rats. Endocrinology 138, 2829-2834.
136. Zhou, Z. X., Lane, M. V., Kemp-painen, J. A., French, F. S., and Wilson, E. M. (1995). Specificity of ligand-dpendent androgen receptor stabilization: receptor domain interactions influence ligand dissociation and receptor stability. Mol. Endocrinol. 9,208-218.